CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		171 Months Ended
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Net sales			$ 69,000
Cost of goods sold			24,120
Gross profit			44,880
Operating expenses	1,937,905	1,082,984	46,082,540
Research and development expenses	167,466	471,355	7,612,463
Non-cash patent settlement cost			1,610,066
Loss before other income	(2,105,371)	(1,554,339)	(55,260,189)
Other income	13,591	65,363	205,563
Interest income			16,342
Interest and financing expense	(2,462,867)	(591,412)	(19,139,484)
Change in fair value of derivative liabilities	(1,139,477)	1,217,597	988,724
Costs of private placement			(1,640,715)
Costs to induce conversion of notes			(469,043)
Loss on disposition of equipment			(14,426)
Settlement of Debt Due Morale/ Matthews			(927,903)
Settlement of litigation and debt	223,774		1,488,796
Loss before provision for income taxes	(5,470,350)	(862,791)	(74,752,335)
Provision for income taxes			7,482
Net loss	$ (5,470,350)	$ (862,791)	$ (74,759,817)
Net loss per common share, basic and diluted (in Dollars per share)	$ (0.05)	$ (0.01)
Weighted average common shares outstanding, basic and diluted (in Shares)	118,213,662	92,826,589